Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: AnVil Gets SBIR Grants To Develop Cancer Drug Software

NEW YORK, May 7-Massachusetts bioinformatics company AnVil said today that it has received two Small Business Innovation Research grants to develop software for cancer drug developers.

 

The grants were awarded by the National Institutes of Health  for $99,225 and $98,328.

 

AnVil will use one grant to merge quantitative cluster comparison metrics with new visualization technologies. The company will then apply this new software tool to a National Cancer Institute compound data set.

 

With the second grant, AnVil will develop new high-dimensional visualization methods for data mining and cancer data analysis.

 

AnVil, based in Burlington, Mass., is privately owned.

 

For further information, see the company's website.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.